{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:00:29Z","timestamp":1792717229513,"version":"4.5.0"},"reference-count":51,"publisher":"SAGE Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JPD"],"published-print":{"date-parts":[[2022,2,15]]},"abstract":"<jats:p>Background: Deep brain stimulation of the sub-thalamic nucleus (DBS-STN) reduces symptoms in Parkinson\u2019s disease (PD) patients with motor fluctuations. However, some patients may not feel ameliorated afterwards, despite an objective motor improvement. It is thus important to find new predictors of patients\u2019 quality of life (QoL) amelioration after DBS-STN. We hypothesized that personality dimensions might affect QoL after DBS-STN. Objective: To evaluate associations between personality dimensions and QoL improvement one year after DBS-STN. Methods: DBS-STN-PD patients (n\u200a=\u200a303) having answered the \u201cTemperament and Character Inventory\u201d (TCI) before surgery and the PDQ-39 before and one year after surgery were included, from the cohort study PREDI-STIM. Linear regression models were used to evaluate associations between TCI dimensions and change in PDQ-39 scores after DBS-STN. Results: Novelty Seeking and Cooperativeness scores before surgery were positively associated with PDQ-39 scores improvement after DBS-STN (FDR-adjusted p\u200a&lt;\u200a0.01). Moreover, paradoxically unimproved patients with deterioration of their PDQ-39 scores after DBS-STN despite improvement of their MDS-UPDRS-IV scores had lower Cooperativeness scores, while paradoxically improved patients with amelioration of their PDQ-39 scores despite deterioration of their MDS-UPDRS-IV scores had higher Reward Dependence scores. Conclusion: Some presurgical personality dimensions were significantly associated with QoL amelioration and discrepancy between motor state and QoL changes after DBS-STN in PD. Educational programs before DBS-STN should take in account patient personality dimensions to better deal with their expectations.<\/jats:p>","DOI":"10.3233\/jpd-212883","type":"journal-article","created":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T14:19:28Z","timestamp":1638886768000},"page":"699-711","source":"Crossref","is-referenced-by-count":14,"title":["Personality Related to Quality-of-Life Improvement After Deep Brain Stimulation in Parkinson\u2019s Disease (PSYCHO-STIM II)"],"prefix":"10.1177","volume":"12","author":[{"given":"Mathilde","family":"Boussac","sequence":"first","affiliation":[{"name":"Toulouse Neuro Imaging Center, University of Toulouse, Inserm, UPS, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the PREDISTIM study group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Arbus","sequence":"additional","affiliation":[{"name":"Psychiatry Department of the University Hospital of Toulouse, CHU Purpan, Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helene","family":"Klinger","sequence":"additional","affiliation":[{"name":"Hospices Civils de Lyon, H\u00f4pital Neurologique Pierre Wertheimer, Service de Neurologie C, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Eusebio","sequence":"additional","affiliation":[{"name":"Aix Marseille Universit\u00e9, AP-HM, H\u00f4pital de La Timone, Service de Neurologie et Pathologie du Mouvement, and UMR CNRS, Institut de Neuroscience de La Timone, NS-PARK\/FCRIN Network, Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elodie","family":"Hainque","sequence":"additional","affiliation":[{"name":"D\u00e9partement de Neurologie, H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re, AP-HP, Paris, France et Facult\u00e9 de M\u00e9decine de Sorbonne Universit\u00e9, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Christophe","family":"Corvol","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9, Paris Brain Institute \u2013ICM, Inserm, CNRS, Assistance Publique H\u00f4pitaux de Paris, Piti\u00e9-Salp\u00eatri\u00e8re Hospital, NS-PARK\/FCRIN, Department of Neurology, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Rascol","sequence":"additional","affiliation":[{"name":"Toulouse Neuro Imaging Center, University of Toulouse, Inserm, UPS, France"},{"name":"Department of Clinical Pharmacology and Neurosciences, Parkinson Expert Center, Clinical Investigation Center, University Hospital of Toulouse, NeuroToul COEN (Center of Excellence in Neurodegeneration), Toulouse, NS-PARK\/FCRIN Network, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Rousseau","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology and Neurosciences, Parkinson Expert Center, Clinical Investigation Center, University Hospital of Toulouse, NeuroToul COEN (Center of Excellence in Neurodegeneration), Toulouse, NS-PARK\/FCRIN Network, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estelle","family":"Harroch","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology and Neurosciences, Parkinson Expert Center, Clinical Investigation Center, University Hospital of Toulouse, NeuroToul COEN (Center of Excellence in Neurodegeneration), Toulouse, NS-PARK\/FCRIN Network, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte Scotto","family":"d\u2019Apollonia","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology and Neurosciences, Parkinson Expert Center, Clinical Investigation Center, University Hospital of Toulouse, NeuroToul COEN (Center of Excellence in Neurodegeneration), Toulouse, NS-PARK\/FCRIN Network, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Croiset","sequence":"additional","affiliation":[{"name":"CERPPS\u2014Study and Research Center in Psychopathology and Health Psychology, University of Toulouse II Jean-Jaur\u00e8s, Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne","family":"Ory-Magne","sequence":"additional","affiliation":[{"name":"Toulouse Neuro Imaging Center, University of Toulouse, Inserm, UPS, France"},{"name":"Department of Clinical Pharmacology and Neurosciences, Parkinson Expert Center, Clinical Investigation Center, University Hospital of Toulouse, NeuroToul COEN (Center of Excellence in Neurodegeneration), Toulouse, NS-PARK\/FCRIN Network, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amaury","family":"De Barros","sequence":"additional","affiliation":[{"name":"Toulouse Neuro Imaging Center, University of Toulouse, Inserm, UPS, France"},{"name":"Department of Neurosurgery, Toulouse University Hospital, Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margherita","family":"Fabbri","sequence":"additional","affiliation":[{"name":"Toulouse Neuro Imaging Center, University of Toulouse, Inserm, UPS, France"},{"name":"Department of Clinical Pharmacology and Neurosciences, Parkinson Expert Center, Clinical Investigation Center, University Hospital of Toulouse, NeuroToul COEN (Center of Excellence in Neurodegeneration), Toulouse, NS-PARK\/FCRIN Network, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Moreau","sequence":"additional","affiliation":[{"name":"Department of Medical Pharmacology, Neurology and Movement Disorders Department, Referent center of Parkinson\u2019s disease, CHU of Lille, Univ. Lille Neuroscience & Cognition, Inserm, UMR-S1172, Licend, Lille, NS-PARK\/FCRIN Network, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Sophie","family":"Rolland","sequence":"additional","affiliation":[{"name":"Department of Medical Pharmacology, Neurology and Movement Disorders Department, Referent center of Parkinson\u2019s disease, CHU of Lille, Univ. Lille Neuroscience & Cognition, Inserm, UMR-S1172, Licend, Lille, NS-PARK\/FCRIN Network, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Benatru","sequence":"additional","affiliation":[{"name":"Neurology Department, University Hospital of Poitiers, Poitiers, France; INSERM, CHU de Poitiers, University of Poitiers, Centre d\u2019Investigation Clinique CIC1402, Poitiers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Anheim","sequence":"additional","affiliation":[{"name":"Service de Neurologie, H\u00f4pitaux Universitaires de Strasbourg; Institut de G\u00e9n\u00e9tique et de Biologie Mol\u00e9culaire et Cellulaire (IGBMC), INSERM-U964\/CNRS-UMR7104\/Universit\u00e9 de Strasbourg, Illkirch; F\u00e9d\u00e9ration de M\u00e9decine Translationnelle de Strasbourg (FMTS), Universit\u00e9 de Strasbourg, Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana-Raquel","family":"Marques","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Clermont Auvergne, CNRS, Clermont Auvergne INP, Institut Pascal, Clermont-Ferrand University Hospital, Neurology department, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Malt\u00eate","sequence":"additional","affiliation":[{"name":"Department of Neurology, Rouen University Hospital and University of Rouen, France; INSERM U1239, Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, Mont-Saint-Aignan, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Drapier","sequence":"additional","affiliation":[{"name":"CHU Rennes, Service de neurologie, CIC-INSERM 1414, Rennes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9chir","family":"Jarraya","sequence":"additional","affiliation":[{"name":"P\u00f4le Neurosciences, Foch Hospital, Suresnes; Universit\u00e9 Paris-Saclay, UVSQ, INSERM U992, CEA Paris-Saclay, Neurospin, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Hubsch","sequence":"additional","affiliation":[{"name":"H\u00f4pital Fondation A de Rothschild, Service de recherche clinique, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Guehl","sequence":"additional","affiliation":[{"name":"Institut des Maladies Neurod\u00e9g\u00e9n\u00e9ratives (IMN, CNRS U5393), Universit\u00e9 de Bordeaux, Bordeaux, France"},{"name":"Service de Neurophysiologie Clinique, P\u00f4le des Neurosciences Cliniques, CHU de Bordeaux, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myl\u00e8ne","family":"Meyer","sequence":"additional","affiliation":[{"name":"Service de neurologie, H\u00f4pital Central, CHRU de Nancy, Nancy Cedex, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiphaine","family":"Rouaud","sequence":"additional","affiliation":[{"name":"Clinique Neurologique, H\u00f4pital Guillaume et Ren\u00e9 Laennec, Boulevard Jacques Monod, Nantes Cedex, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Giordana","sequence":"additional","affiliation":[{"name":"CHU Nice, Department of Psychiatry and Psychotherapy, Nice, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lissa","family":"Tir","sequence":"additional","affiliation":[{"name":"Department of Neurology, Department of Neurosurgery, Expert Centre for Parkinson\u2019s disease, Amiens University Hospital, EA 4559 Laboratoire de Neurosciences Fonctionnelles et Pathologie (LNFP) Universit\u00e9 de Picardie Jules Verne, University of Picardy Jules Verne (UPJV), NS-PARK\/FCRIN Network, Amiens, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Devos","sequence":"additional","affiliation":[{"name":"Department of Medical Pharmacology, Neurology and Movement Disorders Department, Referent center of Parkinson\u2019s disease, CHU of Lille, Univ. Lille Neuroscience & Cognition, Inserm, UMR-S1172, Licend, Lille, NS-PARK\/FCRIN Network, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Brefel-Courbon","sequence":"additional","affiliation":[{"name":"Toulouse Neuro Imaging Center, University of Toulouse, Inserm, UPS, France"},{"name":"Department of Clinical Pharmacology and Neurosciences, Parkinson Expert Center, Clinical Investigation Center, University Hospital of Toulouse, NeuroToul COEN (Center of Excellence in Neurodegeneration), Toulouse, NS-PARK\/FCRIN Network, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JPD-212883_ref1","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1474-4422(08)70291-6","article-title":"Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson\u2019s disease","volume":"8","author":"Benabid","year":"2009","journal-title":"Lancet Neurol"},{"issue":"Suppl 14","key":"10.3233\/JPD-212883_ref2","doi-asserted-by":"crossref","first-page":"S290","DOI":"10.1002\/mds.20962","article-title":"Subthalamic nucleus deep brain stimulation: Summary and meta-analysis of outcomes","volume":"21","author":"Kleiner-Fisman","year":"2006","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-212883_ref3","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1056\/NEJMoa035275","article-title":"Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson\u2019s disease","volume":"349","author":"Krack","year":"2003","journal-title":"N Engl J Med"},{"key":"10.3233\/JPD-212883_ref4","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000093213","article-title":"Chronic deep brain stimulation of the subthalamic nucleus for Parkinson\u2019s disease: effects on cognition, mood, anxiety and personality traits","volume":"55","author":"Castelli","year":"2006","journal-title":"Eur Neurol"},{"key":"10.3233\/JPD-212883_ref5","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1212\/WNL.65.3.499","article-title":"Suicide after successful deep brain stimulation for movement disorders","volume":"65","author":"Albanese","year":"2005","journal-title":"Neurology"},{"key":"10.3233\/JPD-212883_ref6","doi-asserted-by":"crossref","unstructured":"Agid Y , Sch\u00fcpbach M , Gargiulo M , Mallet L , Houeto JL , Behar C , Malt\u00eate D , Mesnage V , Welter ML (2006) Neurosurgery in Parkinson\u2019s disease: the doctor is happy, the patient less so? In Parkinson\u2019s Disease and Related Disorders, Riederer P, Reichmann H, Youdim MBH, Gerlach M, eds. Springer, Vienna, pp. 409\u2013414.","DOI":"10.1007\/978-3-211-45295-0_61"},{"key":"10.3233\/JPD-212883_ref7","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/0885-3924(94)90129-5","article-title":"Quality of life: Concepts and definition","volume":"9","author":"Cella","year":"1994","journal-title":"J Pain Symptom Manage"},{"key":"10.3233\/JPD-212883_ref8","doi-asserted-by":"crossref","first-page":"680659","DOI":"10.1155\/2014\/680659","article-title":"Using the Satisfaction with Life Scale in people with Parkinson\u2019s disease: A validation study in different European countries","volume":"2014","author":"Lucas-Carrasco","year":"2014","journal-title":"ScientificWorldJournal"},{"key":"10.3233\/JPD-212883_ref9","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3406\/psy.2001.29720","article-title":"Le mod\u00e8le biosocial de la personnalit\u00e9 deCloninger","volume":"101","author":"Hansenne","year":"2001","journal-title":"Annee Psychol"},{"key":"10.3233\/JPD-212883_ref10","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1001\/archpsyc.1993.01820240059008","article-title":"A psychobiological model of temperament and character","volume":"50","author":"Cloninger","year":"1993","journal-title":"Arch Gen Psychiatry"},{"key":"10.3233\/JPD-212883_ref11","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.parkreldis.2018.01.013","article-title":"Personality and Parkinson\u2019s disease: A meta-analysis","volume":"49","author":"Santangelo","year":"2018","journal-title":"Parkinsonism Relat Disord"},{"key":"10.3233\/JPD-212883_ref12","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.paid.2006.06.006","article-title":"International comparison of Cloninger\u2019s temperament dimensions","volume":"41","author":"Miettunen","year":"2006","journal-title":"Pers Individ Dif"},{"key":"10.3233\/JPD-212883_ref13","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.psychres.2007.05.003","article-title":"Inter-correlations between Cloninger\u2019s temperament dimensions\u2013a meta-analysis","volume":"160","author":"Miettunen","year":"2008","journal-title":"Psychiatry Res"},{"key":"10.3233\/JPD-212883_ref14","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000070363","article-title":"Combining the Rorschach test and the Temperament Character Inventory: a new perspective on personality assessment","volume":"36","author":"Fassino","year":"2003","journal-title":"Psychopathology"},{"key":"10.3233\/JPD-212883_ref15","first-page":"497","article-title":"Traduction fran\u00e7aise etpremi\u00e8res \u00e9tudes de validation du questionnaire depersonnalit\u00e9 TCI. [Validation study of the French version of theTCI.]","volume":"155","author":"P\u00e9lissolo","year":"1997","journal-title":"Ann Med Psychol (Paris)"},{"key":"10.3233\/JPD-212883_ref16","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.3233\/JPD-191903","article-title":"Personalitydimensions are associated with quality of life in fluctuatingParkinson\u2019s disease patients (PSYCHO-STIM)","volume":"10","author":"Boussac","year":"2020","journal-title":"J Parkinsons Dis"},{"key":"10.3233\/JPD-212883_ref17","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/mds.21198","article-title":"Movement Disorder Society-sponsored revision of the Unified Parkinson\u2019s Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan","volume":"22","author":"Goetz","year":"2007","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-212883_ref18","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1002\/mds.23429","article-title":"Systematic review of levodopa dose equivalency reporting in Parkinson\u2019s disease","volume":"25","author":"Tomlinson","year":"2010","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-212883_ref19","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/BF02260863","article-title":"The development and validation of a short measure of functioning and well being for individuals with Parkinson\u2019s disease","volume":"4","author":"Peto","year":"1995","journal-title":"Qual Life Res"},{"key":"10.3233\/JPD-212883_ref20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000455863","article-title":"Changes inquality of life in Parkinson\u2019s disease: how large must they be to berelevant?","volume":"48","author":"Horv\u00e1th","year":"2017","journal-title":"Neuroepidemiology"},{"key":"10.3233\/JPD-212883_ref21","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.parkreldis.2018.08.018","article-title":"Minimal clinically important difference for the historic parts ofthe Unified Dyskinesia Rating Scale","volume":"58","author":"Makkos","year":"2019","journal-title":"Parkinsonism RelatDisord"},{"key":"10.3233\/JPD-212883_ref22","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1056\/NEJMoa1205158","article-title":"Neurostimulation for Parkinson\u2019s disease with early motorcomplications","volume":"368","author":"Schuepbach","year":"2013","journal-title":"N Engl J Med"},{"key":"10.3233\/JPD-212883_ref23","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1056\/NEJM199810153391603","article-title":"Electrical stimulation of the subthalamic nucleus in advanced Parkinson\u2019s disease","volume":"339","author":"Limousin","year":"1998","journal-title":"N Engl J Mede"},{"key":"10.3233\/JPD-212883_ref24","unstructured":"Morlon EM (2012) Le modele psychobiologique de Cloninger pour evaluer la personnalite du patient douloureux: etude en medecine generale (Thesis). Universite de Limoges."},{"key":"10.3233\/JPD-212883_ref26","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1177\/1049732320951144","article-title":"\u201cHe\u2019s back so i\u2019m not alone\u201d: the impact of deep brain stimulation on personality, self, and relationships in Parkinson\u2019s disease","volume":"30","author":"Thomson","year":"2020","journal-title":"Qual Health Res"},{"key":"10.3233\/JPD-212883_ref27","doi-asserted-by":"crossref","first-page":"e63756","DOI":"10.1371\/journal.pone.0063756","article-title":"Personality traits as risk factors for treatment-resistant depression","volume":"8","author":"Takahashi","year":"2013","journal-title":"PLoS One"},{"key":"10.3233\/JPD-212883_ref28","first-page":"22","article-title":"Theeffects of temperament and character traits on perceived socialsupport and quality of life in patients with epilepsy","volume":"74","author":"Demirci","year":"2017","journal-title":"EpilepsyBehav"},{"key":"10.3233\/JPD-212883_ref29","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.comppsych.2014.12.013","article-title":"Character profiles and life satisfaction","volume":"58","author":"Park","year":"2015","journal-title":"Compr Psychiatry"},{"key":"10.3233\/JPD-212883_ref30","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.psychres.2006.01.004","article-title":"The relationship between dimensional personality models and quality of life in psychiatric outpatients","volume":"149","author":"Masthoff","year":"2007","journal-title":"Psychiatry Res"},{"key":"10.3233\/JPD-212883_ref31","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/ncpneuro0714","article-title":"Psychosocial adjustment after deep brain stimulation in Parkinson\u2019s disease","volume":"4","author":"Sch\u00fcpbach","year":"2008","journal-title":"Nat Clin Pract Neurol"},{"key":"10.3233\/JPD-212883_ref32","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1097\/01.nmd.0000092176.87288.2e","article-title":"Satisfaction with quality of life varies with temperament types of patients with schizophrenia","volume":"191","author":"Ritsner","year":"2003","journal-title":"J Nerv Ment Dis"},{"key":"10.3233\/JPD-212883_ref33","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1037\/0022-3514.89.2.143","article-title":"Goal activation, expectations, and the placebo effect","volume":"89","author":"Geers","year":"2005","journal-title":"J Person Soc Psychol"},{"key":"10.3233\/JPD-212883_ref34","doi-asserted-by":"crossref","first-page":"4882","DOI":"10.1523\/JNEUROSCI.5634-08.2009","article-title":"The anatomy of the mesolimbic reward system: a link between personality and the placebo analgesic response","volume":"29","author":"Schweinhardt","year":"2009","journal-title":"J Neurosci"},{"key":"10.3233\/JPD-212883_ref35","first-page":"17","article-title":"Does personality play a relevant role in the placebo effect?","volume":"25","author":"Jak\u0161i\u0107","year":"2013","journal-title":"Psychiatr Danub"},{"key":"10.3233\/JPD-212883_ref36","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.parkreldis.2003.10.003","article-title":"Uncovering the hidden placeboeffect in deep-brain stimulation for Parkinson\u2019s disease","volume":"10","author":"de la Fuente-Fern\u00e1ndez","year":"2004","journal-title":"Parkinsonism Relat Disord"},{"key":"10.3233\/JPD-212883_ref37","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/bs.irn.2018.07.033","article-title":"The role of patient\u2013practitioner relationships in placebo and nocebo phenomena","volume":"139","author":"Blasini","year":"2018","journal-title":"Int Rev Neurobiol"},{"key":"10.3233\/JPD-212883_ref38","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/ene.12349","article-title":"Relationshipbetween the MDS-UPDRS domains and the health-related quality of lifeof Parkinson\u2019s disease patients","volume":"21","author":"Mart\u00ednez-Mart\u00edn","year":"2014","journal-title":"Eur J Neurol"},{"key":"10.3233\/JPD-212883_ref39","first-page":"871874","article-title":"A review of social and relational aspects of deep brain stimulation in Parkinson\u2019s disease informed by healthcare provider experiences","volume":"2011","author":"Bell","year":"2011","journal-title":"Parkinsons Dis"},{"key":"10.3233\/JPD-212883_ref40","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1017\/S0033291714001081","article-title":"Subjectively perceived personality and mood changes associated with subthalamic stimulation in patients with Parkinson\u2019s disease","volume":"45","author":"Lewis","year":"2015","journal-title":"Psychol Med"},{"key":"10.3233\/JPD-212883_ref41","doi-asserted-by":"crossref","unstructured":"Cloninger CR , Przybeck TR , Svrakic DM , Wetzel RD (1994) The temperament and character inventory (TCI): a guide to its development and use, Center for Psychobiology of Personality, Washington University, St. Louis, MO.","DOI":"10.1037\/t03902-000"},{"key":"10.3233\/JPD-212883_ref42","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1192\/bjp.bp.106.024737","article-title":"Temperament, character and personality disorders as predictors of response to interpersonal psychotherapy and cognitive-behavioural therapy for depression","volume":"190","author":"Joyce","year":"2007","journal-title":"Br J Psychiatry"},{"key":"10.3233\/JPD-212883_ref43","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0165-0327(97)00030-X","article-title":"Serotonergic autoreceptor blockade in the reduction of antidepressant latency: personality variables and response to paroxetine and pindolol","volume":"44","author":"Tome","year":"1997","journal-title":"J Affect Disord"},{"key":"10.3233\/JPD-212883_ref44","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.genhosppsych.2008.06.003","article-title":"Personality and attrition from behavioral weight-loss treatment for obesity","volume":"30","author":"De Panfilis","year":"2008","journal-title":"Gen Hosp Psychiatry"},{"key":"10.3233\/JPD-212883_ref45","doi-asserted-by":"crossref","first-page":"e0245142","DOI":"10.1371\/journal.pone.0245142","article-title":"Personality dimensions of patients can change duringthe course of parkinson\u2019s disease","volume":"16","author":"Boussac","year":"2021","journal-title":"PLoS One"},{"key":"10.3233\/JPD-212883_ref46","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1002\/mds.27065","article-title":"Personality,dopamine, and Parkinson\u2019s disease: Insights from subthalamicstimulation","volume":"32","author":"Lhomm\u00e9e","year":"2017","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-212883_ref47","first-page":"490507","article-title":"Personality changes after deep brain stimulation in Parkinson\u2019s disease","volume":"2015","author":"Pham","year":"2015","journal-title":"Parkinsons Dis"},{"key":"10.3233\/JPD-212883_ref48","first-page":"62","article-title":"Novelty-seeking in Parkinson\u2019s disease after deep brain stimulation of the subthalamic nucleus: a case-control study","volume":"51","author":"Fassino","year":"2010","journal-title":"Psychosomatics"},{"key":"10.3233\/JPD-212883_ref49","unstructured":"Dupouy J (2014) Personnalit\u00e9 et maladie de Parkinson idiopathique: \u00e0 propos d\u2019une revue de la litt\u00e9rature et de deux \u00e9tudes exp\u00e9rimentales (Thesis). Universit\u00e9 Toulouse."},{"key":"10.3233\/JPD-212883_ref50","doi-asserted-by":"crossref","first-page":"356","DOI":"10.9734\/INDJ\/2014\/11740","article-title":"Personality and deep brain stimulation of the subthalamic nucleus in Parkinson\u2019s disease","volume":"2","author":"Abbate-Daga","year":"2014","journal-title":"Int Neuropsychiatr Dis J"},{"key":"10.3233\/JPD-212883_ref51","doi-asserted-by":"crossref","first-page":"16024","DOI":"10.1038\/npjparkd.2016.24","article-title":"The effect of deep brain stimulation on the non-motor symptoms of Parkinson\u2019s disease: a critical review of the current evidence","volume":"3","author":"Kurtis","year":"2017","journal-title":"NPJ Parkinsons Dis"},{"key":"10.3233\/JPD-212883_ref52","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jns.2015.04.013","article-title":"Relationship between the non-motor items of the MDS\u2013UPDRS and Quality of Life in patients with Parkinson\u2019s disease","volume":"353","author":"Skorvanek","year":"2015","journal-title":"J Neurol Sci"}],"container-title":["Journal of Parkinson's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JPD-212883","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T04:51:00Z","timestamp":1777611060000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JPD-212883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,15]]},"references-count":51,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3233\/jpd-212883","relation":{},"ISSN":["1877-7171","1877-718X"],"issn-type":[{"value":"1877-7171","type":"print"},{"value":"1877-718X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,15]]}}}